不明原因生育力低下宫腔内人工授精中促排卵使用促卵泡激素或枸橼酸氯米芬:治疗选择标志物是否有作用?
该研究为多中心随机对照优势试验SUPER研究的二次分析,纳入2013年7月至2016年3月不明原因生育力低下接受宫腔内人工授精的夫妇,比较促卵泡激素(FSH)与枸橼酸氯米芬促排卵的持续妊娠情况。共684对夫妇接受2259个IUI周期,FSH组338对中84对持续妊娠,枸橼酸氯米芬组346对中71对持续妊娠。未发现任何基线治疗选择标志物能识别FSH较枸橼酸氯米芬更有利于持续妊娠的人群。
要点
- SUPER研究二次分析:684对不明原因生育力低下夫妇,2259个IUI周期。
- FSH组338对中84对持续妊娠,枸橼酸氯米芬组346对中71对持续妊娠。
- 无基线治疗选择标志物与FSH较枸橼酸氯米芬更好的持续妊娠机会相关。
核心结论
- 在不明原因生育力低下接受IUI的夫妇中,未识别出任何基线治疗选择标志物可决定卵巢应采用FSH还是枸橼酸氯米芬刺激。
研究设计与样本
- 多中心随机对照优势试验SUPER研究的二次分析,2013年7月至2016年3月纳入不明原因生育力低下接受IUI的夫妇。
- 共684对夫妇接受2259个IUI周期;338对分配至FSH组,346对分配至枸橼酸氯米芬组。
- 评估女性年龄、体重指数、生育力低下持续时间、原发与继发生育力低下、窦卵泡计数和总活动精子数。
主要发现
- FSH组338对中84对获得持续妊娠,枸橼酸氯米芬组346对中71对获得持续妊娠。
- 未发现任何治疗选择标志物与FSH较枸橼酸氯米芬更好的持续妊娠机会相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Can women be identified, on the basis of baseline patient characteristics, as having better chances of an ongoing pregnancy with FSH instead of clomiphene citrate as stimulation agent in intrauterine insemination for unexplained subfertility? DESIGN: A secondary analysis of a multicentre randomized controlled superiority trial; the SUPER study. Between July 2013 and March 2016, couples with unexplained subfertility undergoing intrauterine inemination (IUI) were allocated to an FSH or clomiphene citrate group. Female age, body mass index, duration of subfertility, primary versus secondary subfertility, antral follicle count and total motile count were assessed. For each of these factors, a logistic regression model was developed to assess if different estimated effects of FSH versus clomiphene citrate on ongoing pregnancy occurred within strata of each factor. RESULTS: A total of 684 couples received 2259 IUI cycles; 338 couples were allocated to FSH, of which 84 conceived leading to ongoing pregnancy and 346 couples were allocated to clomiphene citrate, of which 71 conceived leading to ongoing pregnancy. None of the treatment selection markers was associated with better ongoing pregnancy chances after IUI with FSH compared with clomiphene citrate. CONCLUSION: In couples with unexplained subfertility undergoing IUI, no baseline treatment selection markers could be identified to determine whether ovaries should be stimulated with FSH or clomiphene citrate.
引用
- Danhof NA, van Eekelen R, Repping S, et al. Follicle stimulating hormone or clomiphene citrate in intrauterine insemination with ovarian stimulation for unexplained subfertility: a role for treatment selection markers? Reprod Biomed Online. 2019. PMID: 30981620. doi:10.1016/j.rbmo.2019.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。